Results 111 to 120 of about 690 (122)
Some of the next articles are maybe not open access.
EM.P.1.04 Treatment approaches in laminin-α2-deficient congenital muscular dystrophy (MDC1A)
Neuromuscular Disorders, 2009S. Meinen, S. Lin, M.A. Rüegg
openaire +1 more source
Widening the spectrum of LAMA 2 congenital muscular dystrophy (MDC1A): cobblestone malformation
Arquivos De Neuro-Psiquiatria, 2022Thiago Rezende +2 more
exaly
P289 – 2042 Merosin-deficient congenital muscular dystrophy type 1A (MDC1A): a case report
European Journal of Paediatric Neurology, 2013C Graf von Kalckreuth +6 more
openaire +1 more source
During the development of this project, we have focused on expanding the adeno-virus associate (AAV) delivery tool capacity to potentially treat any monogenic disease. Several AAV-based therapies have obtained marketing authorization in recent years. Nonetheless, the potential use of AAVs is constrained by their limited gene packaging capacity, which ...
openaire +1 more source
openaire +1 more source
Laminin alpha2 negative congenital muscular dystrophy (MDC1A) presenting with a mild phenotype
2003PRANDINI P +4 more
openaire +1 more source

